Categoría

Comunicaciones y Congresos

Home > Comunicaciones y Congresos (Page 39)

Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R

 

 

Cost-effectiveness of two oral antiviral therapies, lamivudine and adefovir dipivoxil of HBeAg-negative chronic hepatitis B
40th Annual Meeting of the European Association for the Study of the Liver (EASL). Paris, France. 13-17 apr 2005

Buti M, Wong J, Casado MA, Esteban R

 

 

 

Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patients. Co-infected Patients
1st European Consensus Conference on the Treatment of Chronic Hepatitis B and C in HIV. Paris, France. 1-2 mar 2005

Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R

 

 

Análisis coste-efectividad de dos tratamientos antivirales de administración oral, lamivudina y adefovir dipivoxil, en pacientes HBeAg negativos con hepatopatía compensada
XXX Congreso Nacional de la Asociación Española para el Estudio del Hígado (AEEH). Madrid, España. 17-19 feb 2005

Buti M, Casado MA, Fosbrook L, Esteban R

 

 

 

Budget impact analysis of two different methods of evaluating EVR to peginterferon alfa-2b (PegIntron?) plus ribavirin (Rebetol) in genotype 1 naïve patients with chronic hepatitis C
55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). Boston, Massachusetts, EEUU. 29 oct-2 nov 2004

ACRMaymó J, Pérez C, Poveda JL, Casado MA, Fosbrook L, Merino P

 

 

Cost-analysis of infliximab and etanercept in the treatment of rheumatoid artritis patients in Spain, based on a Pharmacoeconomic model, and budgetary impact analysis of the results
Annual Scientific Meeting of American College of Rheumatology (ACR). San Antonio, Texas. 16-21 oct 2004

Wong JB, Ballina J, Fernández-Sueiro JL, García-Vadillo JA, González-Fernández C, González-Crespo MR, Gratacós J, Ivorra J, Navarro F, Tornero J, Casado MA, Fosbrook L, Pocovi A

 

Cost-effectiveness of infliximab for rheumatoid arthritis in Spain
4th Annual Congress of Rheumatology of the European League Against Rheumatism (EULAR). Berlin, Germany. 9-12 jun 2004

Wong JB, Ballina J, Fernández-Sueiro JL, García-Vadillo JA, González-Fernández C, González-Crespo MR, Gratacós J, Ivorra J, Navarro F, Tornero J, Casado MA, Fosbrook L, Pocovi A

 

Coste-efectividad de infliximab en pacientes con artritis reumatoide en España
XXX Congreso Nacional de la Sociedad Española de Reumatología (SER). Barcelona, España. 19-21 may 2004

Davies G, Yin D, Alemao E, Nocea G, Casado MA, Veltri E, Cook J

 

 

The economic assessment of lipid lowering therapy with ezetimibe vs atorvastatin titration in Spain
74th European Atherosclerosis Society (EAS) Congress. Seville, Spain. 17-20 apr 2004

Garcia-Ruiz FJ, Marin-Ibañez A, Perez-Jiménez F, Pinto X, Nocea G, Casado MA, Erbey J, Alemao E, Yin D

 

 

LDL-cholesterol goal attainment among patients treated with lipid lowering drugs in Spain
74th European Atherosclerosis Society (EAS) Congress. Seville, Spain. 17-20 apr 2004